Triple Therapy for HER2-Positive Gastric Cancer Shrinks Tumors

The addition of pembrolizumab (Keytruda) to trastuzumab (Herceptin) and platinum-based chemotherapy led to a significant improvement in overall response rate.
Medscape Medical News

source https://www.medscape.com/viewarticle/965360?src=rss